Basics Lifecore Biomedical, Inc. IPO Date: March 1, 1996 Sector: Healthcare Industry: Drug Manufacturers - Specialty and Generic Market Cap: $259.18M Activated in VL: True Average Daily Range Avg Daily Range: $0.19 | 3.06% Avg Daily Range (30 D): $0.15 | 2.31% Avg Daily Range (90 D): $0.15 | 2.48% Institutional Daily Volume Avg Daily Volume: .26M Avg Daily Volume (30 D): .18M Avg Daily Volume (90 D): .17M Trade Size Avg Trade Size (Sh.): 95 Avg Trade Size (Sh.) (30 D): 69 Avg Trade Size (Sh.) (90 D): 71 Institutional Trades Total Inst.Trades: 24 Avg Inst. Trade: $2.96M Avg Inst. Trade (30 D): $3.9M Avg Inst. Trade (90 D): $3.26M Avg Inst. Trade Volume: .42M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $6.32M Avg Closing Trade (30 D): $3.54M Avg Closing Trade (90 D): $2.62M Avg Closing Volume: 880.05K         News Mar 17, 2025 @ 11:00 AM Humanetics Selects Lifecore Biomedical to Deliver ... Source: N/A Jan 17, 2025 @ 10:24 PM Lifecore Biomedical Announces Special Stockholder ... Source: N/A Jan 7, 2025 @ 2:00 PM Lifecore Biomedical Further Strengthens Financial ... Source: N/A Jan 3, 2025 @ 11:42 AM US Stocks Poised To Open Higher As Futures Advance... Source: Rishabh Mishra Nov 7, 2024 @ 12:00 PM Lifecore Biomedical to Host Virtual Investor Day P... Source: N/A Financials   TTM Q2 2025 Q1 2025 Basic EPS $-.47 $-.25 $-.53 Diluted EPS $-.47 $-.25 $-.53 Revenue $ 35.15M $ 32.56M $ 24.71M Gross Profit $ 9.85M $ 11.08M $ 5.39M Net Income / Loss $ -14.77M $ -6.57M $ -16.23M Operating Income / Loss $ -9.03M $ -1.96M $ -11.58M Cost of Revenue $ 25.31M $ 21.48M $ 19.32M Net Cash Flow $ -4.04M $ 3.94M $ -2.94M PE Ratio